Syros Pharmaceuticals Inc (SYRS)

Syros Pharmaceuticals Inc (SYRS) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $10,732; returns 1 day +0.0%.

Syros Pharmaceuticals Inc. (SYRS) is a biopharmaceutical company focused on developing treatments for hematologic malignancies. However, recent events indicate a significant downturn in the company's prospects. Syros's failure to meet the primary endpoint in its pivotal clinical trial resulted in the elimination of its business prospects and forced the complete shutdown of operations.

Groups SYRS belongs to

• Healthcare
• Biotechnology
• Pharmaceuticals
• Hematologic Malignancies
• Oncology
• Hematology

SYRS financial model: income statement, cash flow and balance sheet